Geometry.Net - the online learning center
Home  - Health_Conditions - Hereditary Angioedema
e99.com Bookstore
  
Images 
Newsgroups
Page 4     61-80 of 104    Back | 1  | 2  | 3  | 4  | 5  | 6  | Next 20
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

         Hereditary Angioedema:     more detail
  1. A Selection of Important Papers in Hereditary Angioedema: A Compilation of Key Peer-Reviewed Papers From Leading Journals
  2. Urticaria and Angioedema: Anaphylaxis, Solar Urticaria, Angioedema, Cold Urticaria, Dermatographic Urticaria, Hereditary Angioedema
  3. Study finds C1-inhibitor concentrate is safe and effective in treating skin swelling in patients with hereditary angioedema.(GENERAL DERMATOLOGY)(use of ... An article from: Dermatology Nursing by Daniel B. Burfeind, 2007-06-01
  4. Erythema marginatum and hereditary angioedema.(Original Article): An article from: Southern Medical Journal by John C. Starr, George W. Brasher, et all 2004-10-01
  5. Clinical Review of Hereditary Angioedema (Postgraduate Medicine) by MD Mark Weis, 2010-05-16
  6. Icatibant promising for hereditary angioedema.(News): An article from: Skin & Allergy News by Nancy Walsh, 2007-07-01
  7. Hereditary angioedema: a case study.(Case study)(Clinical report): An article from: Journal of Neuroscience Nursing by Vincent M., Jr. Vacca, 2007-10-01
  8. Hereditary angioedema.: An article from: Journal of Drugs in Dermatology by Michael M. Sachse, Amor Khachemoune, et all 2006-10-01

61. Clinical Trial: C1-Esteraseremmer-N For The Treatment Of Hereditary (and Acquire
Inclusion criteria for hereditary angioedema patients. Established diagnosis of hereditary angioedema type I or II markedly decreased C1 inhibitor
http://www.clinicaltrials.gov/ct/show/NCT00125541
Home Search Browse Resources ... About C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema This study is not yet open for patient recruitment.
Verified by Sanquin July 2005 Sponsored by: Sanquin Information provided by: Sanquin ClinicalTrials.gov Identifier: Purpose In part C of the study, a number of HAE patients will be treated prophylactically with open-label C1-esteraseremmer-N for a period of 16 weeks. The number of attacks occurring will be compared with historical data. If possible, also some patients treated prophylactically with C1 inhibitor for acquired angioedema will be included. Condition Intervention Phase Angioedema
Drug: C1 inhibitor concentrate (C1-esteraseremmer-N)
Phase II

Phase III

MedlinePlus
related topics: Hives Vascular Diseases
Study Type: Interventional
Study Design: Prevention, Non-Randomized, Open Label, Historical Control, Single Group Assignment, Safety/Efficacy Study Official Title: Pharmacokinetics, Clinical Efficacy and Safety of C1 Inhibitor Concentrate (C1-Esteraseremmer-N) for the Treatment of Hereditary (and Acquired) Angioedema Further Study Details: Primary Outcomes: The primary objective in this clinical study is to evaluate the prevention of angioedema attacks in patients prophylactically treated with C1-esteraseremmer-N.

62. Clinical Trial: Subcutaneous Treatment With Icatibant For Acute Attacks Of Hered
cutaneous and/or abdominal attacks in patients with hereditary angioedema (HAE). Formulation of Icatibant for the Treatment of hereditary angioedema
http://www.clinicaltrials.gov/ct/gui/show/NCT00097695
Home Search Browse Resources ... About Subcutaneous Treatment with Icatibant for Acute Attacks of Hereditary Angioedema This study is currently recruiting patients.
Verified by Jerini AG September 2005 Sponsored by: Jerini AG Information provided by: Jerini AG ClinicalTrials.gov Identifier: Purpose The purpose of this study is to assess the efficacy and safety of Icatibant, a bradykinin antagonist in the treatment of acute cutaneous and/or abdominal attacks in patients with hereditary angioedema (HAE). Condition Intervention Phase Angioedema
Drug: Icatibant
Phase II

Phase III

MedlinePlus
related topics: Hives Vascular Diseases
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study Official Title: Randomized, Double Blind, Placebo-Controlled, Multicenter Study of a Subcutaneous Formulation of Icatibant for the Treatment of Hereditary Angioedema Further Study Details: Primary Outcomes: Symptom relief (patient)
Secondary Outcomes: Safety and tolerability; Additional efficacy assessments; Pharmacoeconomics
Expected Total Enrollment: 56 Study start: August 2004
Eligibility Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both

63. Current Clinical Trial Studies
Diagnosed with hereditary angioedema. Exclusion Criteria, Pregnant, breastfeeding, abnormal liver or kidney function. Length of Study, 28 days
http://www.hmc.psu.edu/clinicaltrials/studies/weblistings/2003-255.htm

64. Recombinant Human C1 Inhibitor Trial Shows Positive Results In Treating Heredita
hereditary angioedema is a genetic disorder caused by a deficiency of the Pharming s lead product (rhC1INH) for hereditary angioedema is in Phase III of
http://www.rxpgnews.com/research/pharmacology/article_1331.shtml
news channels for medical professionals Research Health Careers World ... Climate Search
All Categories Latest Research Cancer Breast Skin Blood Non-Hodgkin's Lymphoma Multiple Myeloma Prostate Liver Colon Thyroid Endometrial Brain Glioblastoma Multiforme Therapy Pharmacotherapy Radiotherapy Vaccination Risk Factors Esophageal Bladder Lung Small Cell Carcinoma Rectal Cancer Pancreatic Cancer Bone Cancer Ewing's Sarcoma Cervical Cancer Testicular Cancer Gastric Cancer Ovarian Cancer Nerve Tissue Acoustic Neuroma Psychiatry Depression Neuropsychiatry Personality Disorders Bulimia Anxiety Phobia Panic Disorders Stress PTSD GAD Agoraphobia OCD Social Phobia Substance Abuse Alcohol Smoking Amphetamine Opiates Suicide

65. DX-88 : A Recombinant Small Protein Shows Significant Benefit In Hereditary Angi
The prevalence of hereditary angioedema is believed to be between 1/10000 and 1/50000 people worldwide. The condition is caused by a genetic deficiency of
http://www.rxpgnews.com/research/pharmacology/article_800.shtml
news channels for medical professionals Research Health Careers World ... Climate Search
All Categories Latest Research Cancer Breast Skin Blood Non-Hodgkin's Lymphoma Multiple Myeloma Prostate Liver Colon Thyroid Endometrial Brain Glioblastoma Multiforme Therapy Pharmacotherapy Radiotherapy Vaccination Risk Factors Esophageal Bladder Lung Small Cell Carcinoma Rectal Cancer Pancreatic Cancer Bone Cancer Ewing's Sarcoma Cervical Cancer Testicular Cancer Gastric Cancer Ovarian Cancer Nerve Tissue Acoustic Neuroma Psychiatry Depression Neuropsychiatry Personality Disorders Bulimia Anxiety Phobia Panic Disorders Stress PTSD GAD Agoraphobia OCD Social Phobia Substance Abuse Alcohol Smoking Amphetamine Opiates Suicide

66. AADMC: Selected Articles 2000: Laryngeal Obstruction In Hereditary Angioedema
Laryngeal obstruction in hereditary angioedema. Summary Airway obstruction, a major cause of mortality in hereditary angioedema (HAE) is frequently not
http://www.aaaai.org/aadmc/currentliterature/selectedarticles/2000archive/laryng
SELECTED ARTICLES FROM THE RECENT LITERATURE 2000 Laryngeal obstruction in hereditary angioedema Summary
Airway obstruction, a major cause of mortality in hereditary angioedema (HAE) is frequently not recognized promptly, sometimes with disastrous results. Bork et al of the University of Mainz in Germany reviewed details of 6 HAE patients who died because of laryngeal edema in Germany over a 10 year period. The interval between first symptoms and asphyxiation was 1-14 hours. No patient had an urgent cricothyrotomy or replacement C1 inhibitor concentrate. A retrospective review of 58 HAE cases in Germany, revealed 23 deaths by asphyxiation with an average age at death of 39 years. Reference
Mayo Clinic Proc 2000'75:349-54 Editor's Comments
Although HAE is not a common disorder, I have reviewed this report because it emphasizes: 1) that laryngeal obstruction is common in HAE and is a frequent cause of death at a relatively young age; 2) the first episode of laryngeal edema can be fatal; 3) although the disorder is congenital, most airway fatalities occur in young adults/middle age; 4) most important, such tragic outcomes can be prevented by appropriate chronic and emergency treatment. American Academy of Allergy, Asthma and Immunology

67. Icatibant - A New Approach For Hereditary Angioedema
Icatibant a new approach for hereditary angioedema. Summary potentially fatal episodes of hereditary angioedema (HAE) has not been very satisfactory.
http://www.aaaai.org/aadmc/currentliterature/selectedarticles/2005archive/icatib
SELECTED ARTICLES FROM THE RECENT LITERATURE 2005
Icatibant - a new approach for hereditary angioedema
Summary
Background - The treatment of acute, potentially fatal episodes of hereditary angioedema (HAE) has not been very satisfactory. It is generally agreed that bradykinin (Bk) is the major mediator of angioedema in such episodes. Findings - Icatibant (Icat) is a potent, selective peptidomimetric antagonist of the bradykinin beta 2-receptor. As reviewed in this report, Icat appears to be the first such an antagonist that does not also stimulate this Bk receptor. Preliminary studies of Icat use by either IV or subcutaneous formulations showed very encouraging results with no evidence of adverse effects. Therefore, Jenini AG, a German pharmaceutical company has initiated controlled Phase IIb studies of Icat treatment for acute HAE episodes. Reference
Drugs RD 2004;5:343-8 Editor's Comments
I have briefly reviewed the preliminary findings described above because of the potential value of this treatment. The frequency and/or severity of acute HAE episodes is often (nut not always) reduced by maintenance therapy with altered androgens (danazol, stanazolol). However, there is still a potential risk for a possibly fatal acute HAE reaction. Treatment with plasmin inhibitors (e.g. - EACA) has yielded inconsistent benefit and/or adverse side-effects. A plasma fraction containing the C1 esterase inhibitor is available in several European countries (but not the USA ) for treatment of acute HAE episodes. Icat looks sufficiently promising so that the FDA has awarded a "fast track" review of the results of Icat trials in HAE as well as an "orphan drug" status.

68. Sally's World: Hereditary Angioedema
hereditary angioedema is a rare inherited form that differs from other types of Check out the United States hereditary angioedema Association and the
http://www.sallyalexander.com/2005/06/hereditary_angi.html
hostName = '.sallyalexander.com';
Sally's World
Photo Albums
Roomba
News Links
South African News
Iraq links
Food Blogs
Archives
Powered by TypePad
Member since 12/2003 Main
Hereditary Angioedema
Hereditary Angioedema is " a rare inherited form that differs from other types of angiodema. It is not triggered by an allergic reaction and involves deep tissue swelling and is never associated with hives. Swelling in the gastrointestinal tract can led to severe pain in the abdomen and can be mistaken for appendicitis. Hereditary angiodema can be detected through blood tests and can be effectively treated with special hormone medications." Reference here.

69. Thesis
hereditary angioedema Quincke first described and named angioneurotic edema (1), the striking influence of mental stress on the disorder led to the term
http://www.nss.nl.no/utdanning/thesis/intro1.htm
Meny: STARTSIDE AVDELINGER PASIENTINFO HELSEPERSONELLINFO ... Klipp fra presse/media Web-ansvar:
I nformasjonsleder Randi Angelsen og
spesialsykepleier
Knut Dybwik
Previous: Abbreviations
Introduction Hereditary angioedema
Quincke first described and named angioneurotic edema (1), the striking influence of mental stress on the disorder led to the term neurotic which now is abandoned as the genetic cause is known. Nathaniel Hawthorne was apparently familiar with this disorder for in his 'House of the Seven Gables' (2), he describes the Pyncheon family with members who gurgled in the throat and chest when excited and who would sometimes die this way, ever since a curse to choke on blood had been placed on one of their ancestors. The following passages could indicate that Hawthorne recognised that a hereditary disease, not a curse, was responsible for the deaths: "This mode of death has been an idiosyncrasy with his family, for generations past" and "the curse,.. had become a part of the Pyncheon inheritance" (3).
Persons with hereditary angiodema are victims of recurrent bouts of edema which may occur in nearly every part of the body (Fig. 1 - 3). Attacks typically last for 2 to 5 days. The disease has been reviewed in several papers (4-11).

70. PiA - Primary Immunodeficiency Association - Common Variable Immunodeficiency CV
What Is hereditary angioedema? (taken from www.hereditaryangioedema.com). hereditary angioedema (HAE) is a rare and serious genetic condition occurring in
http://www.pia.org.uk/hae/
Home HAE Publications Services ... Helpline
Welcome to the Hereditary Angioedema (HAE) Pages
What Is Hereditary Angioedema?
(taken from www.hereditaryangioedema.com
Hereditary Angioedema (HAE) is a rare and serious genetic condition occurring in about 1/10,000 to 1/50,000 individuals. The disease is characterized by episodes of edema (swelling) in body parts, most notably the hands, feet, face, and airway passages. In addition, patients often have bouts of excruciating abdominal pain, nausea, and vomiting that is caused by swelling in the intestinal wall.
HAE patients have a defect in the gene that controls a blood protein called C1-inhibitor. The genetic defect results in production of either inadequate or nonfunctioning C1-inhibitor protein. Normal C1-inhibitor helps to regulate the complex biochemical interactions of blood based systems involved in disease fighting, inflammatory response, and coagulation. Because defective C1-inhibitor does not adequately perform its regulatory function, a biochemical imbalance can occur and produce unwanted peptides that induce the capillaries to release fluids into surrounding tissues, thereby causing edema.
HAE is called hereditary because the genetic defect is passed on in families. A child has a 50 percent chance of inheriting this disease if one of his or her parents has it. The absence of family history does not rule out the HAE diagnosis, however. Scientists report that as many as 20 percent of HAE cases result from patients who had a spontaneous mutation of the C1-inhibitor gene at conception. These patients can pass the defective gene to their offspring.

71. OB-GYN-L Messages For June, 1996: Hereditary Angioedema
hereditary angioedema. From STEWART PRINGLE (100724.2333@CompuServe.COM) Fri Jun 14 163134 1996. Messages sorted by date thread subject
http://forums.obgyn.net/ob-gyn-l/OBGYNL.9606/0285.html
-VISIT OUR OTHER FORUMS- OB-GYN-L Ultrasound Ultrasound History Physicians-in-Training Tech Talk OBSTET-L (portuguese) OBGIN-L (spanish) Nursing
hereditary angioedema
From: STEWART PRINGLE 100724.2333@CompuServe.COM
Fri Jun 14 16:31:34 1996
I have a 21 yr old with angioedema ( C1 esterase inhibitor deficiency). She's never had any airway problems but has attacks at other sites quite often. She has a Bartholin's cyst which I propose to marsupialise. Firstly does anyone know about the anaesthetic implcations? Next she has some dysmen not helped by an NSAID and says the combined OC pill makes her angioedema worse. She needs contraception too having already had 1 unwanted pregnancy and I suggested DepoProvera so for bonus marks is that OK with her condition? Stewart Pringle Glasgow, UK

72. OB-GYN-L Messages For June, 1996: Re: Hereditary Angioedema
Online Free service ; In reply to Malcolm Griffiths Re hereditary angioedema ; Next in thread Paula R. Dhanda Re hereditary angioedema
http://forums.obgyn.net/ob-gyn-l/OBGYNL.9606/0298.html
-VISIT OUR OTHER FORUMS- OB-GYN-L Ultrasound Ultrasound History Physicians-in-Training Tech Talk OBSTET-L (portuguese) OBGIN-L (spanish) Nursing
Re: hereditary angioedema
From: Malcolm Griffiths Malcolm@mgriff22.demon.co.uk
Sat Jun 15 17:53:14 1996
Malcolm@mgriff22.demon.co.uk
100724.2333@CompuServe.COM

Sorry - doesn't necessarily answer her contraception problems, but ... Malcolm Malcolm@mgriff22.demon.co.uk "It is dangerous to be right on a subject on which the established authorities are wrong." (Voltaire)

73. Dorlands Medical Dictionary
hereditary angioedema, inherited C1 inhibitor (C1 INH) deficiency, an autosomal dominant disorder manifested as recurrent episodes of edema of the skin,
http://www.merckmedicus.com/pp/us/hcp/thcp_dorlands_content.jsp?pg=/ppdocs/us/co

74. ALLSA - Urticaria And Angioedema
Cholinergic Urticaria; Cold Urticaria; hereditary angioedema (HAO) hereditary angioedema (HAO) Index. HAO is caused by a deficiency of the C1 inhibitor
http://www.allergysa.org/urticariahdbook.htm

Handbook
Urticaria and Angioedema
Written by Dr Cassim Motala Urticaria may be acute ( 6 weeks duration). Angioedema is frequently associated with urticaria but the two may occur independently. A. Incidence
Index
Acute urticaria is said to affect 10%-20% of the population at some time during life. It is not uncommon in childhood, but the greatest incidence appears to be in young adults (15%). Chronic urticaria occurs more frequently in mid-life, especially in women. B. Aetiology
Index
A clinical classification is given in Table 1. In chronic urticaria a causative agent or precipitating cause may be established in only about 10% to 30% of cases. Therefore, most chronic urticaria is idiopathic. In acute urticaria the chances of determining the cause are higher. For example as many cases of acute urticaria in children may be associated with a viral, bacterial or parasitic infection (not always clinically apparent). Acute urticaria and angiooedema may also be caused by allergen exposure including insect stings or food or drug ingestion. Some of the more common drugs include penicillin, cephalosporins and sulphonamides. Opiates may act directly on mast cells to cause histamine release. Aspirin and other non-steroidal anti-inflammatory agents can cause urticaria or angioedema in the same way. Angiotensin converting enzyme inhibitors are a common cause of drug induced angioedema.

75. Health Encyclopedia
hereditary angioedema is an inherited abnormality of the immune system that causes swelling , particularly of the face, and abdominal cramping.
http://healthcontent.baptisteast.com/adamcontent/ency/article/001456.asp
Member Sign In Visitors/Patients Physicians/Clinicians Employees Search: About Baptist Services Education Health Information ... Contact Us Printer Friendly Send to a Friend Search Health Encyclopedia
Click here

Disease
Injury ... Test
Hereditary angioedema
Antibodies

Overview
Symptoms Treatment ... Prevention
Definition
Hereditary angioedema is an inherited abnormality of the immune system that causes swelling , particularly of the face, and abdominal cramping. Also, see angioedema
Causes and Risk
Hereditary angioedema is an inherited disorder. It is caused by the absence of a protein called C1 inhibitor (or a defect in this protein), which in turn effects blood vessels. People with hereditary angioedema can develop rapid swelling of the hands, feet, limbs, face, intestinal tract, or airway (larynx or trachea). Unlike an allergic reaction , there is usually no itching or hives . Swelling of the gut can cause intestinal cramping. If swelling closes the airway, it can be fatal. Attacks of swelling can become more severe in late childhood and adolescence. A family history is usually noted, at times only reported to descendants as an unexpected, sudden, and premature death of a parent, aunt/uncle, or grandparent.

76. Hereditary Angioedema In A Chinese Family
hereditary angioedema is characterised by recurrent episodes of We report a familial cluster of hereditary angioedema in a Chinese family and describe
http://www.hkmj.org.hk/hkmj/abstracts/v3n4/436.htm
About the HKMJ Subscriptions Reprints Search past issues
Hereditary angioedema in a Chinese family
D Choy, A Ho, JKW Chan, CKW Lai, E Li, R Leung
Department of Medicine, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong Hereditary angioedema is characterised by recurrent episodes of peri-orbital and peri-oral swelling which can cause an upper airway obstruction, abdominal pain, vomiting, diarrhoea, and even hypotensive collapse. This potentially fatal condition is frequently misdiagnosed; its early recognition and appropriate treatment are thus important. We report a familial cluster of hereditary angioedema in a Chinese family and describe the clinical course of two patients.
HKMJ 1997;3(4):436-8
Key words: Angioneurotic edema; Complement 1 inactivators; Immunologic deficiency syndromes
Full-text article
Previous abstract Next abstract The issue's contents ... Volume index

77. Hereditary Angioedema With Recurrent Abdominal Pain. Seth Avnish K, Nair V, Sing
Indian J Gastroenterol, The official publication of the Indian Society of Gastroenterology (ISG)
http://www.indianjgastro.com/article.asp?issn=0254-8860;year=2002;volume=21;issu

78. Indian Pediatrics - Case Reports
Case Reports. Indian Pediatrics 2000;37 431432. hereditary angioedema ‘Type I’ Report of a Family with a Fatal Case
http://www.indianpediatrics.net/april2000/april-431-432.htm
Home Past Issue About IP About IAP ... Subscription Case Reports Indian Pediatrics 2000;37: 431-432 Hereditary Angioedema ‘Type I’: Report of a Family with a Fatal Case Gurvinder P . Thami
Amrinder J. Kanwar
From the Department of Dermatology and Venereo-logy, Government Medical College Hospital, Sector 32, Chandigarh 160 047, India.
Reprint requests: Dr. A.J. Kanwar, Professor and Head, Department of Dermatology and Venereology, Government Medical College Hospital, Sector 32, Chandigarh 160 047, India. Manuscript Received: August 10, 1999;
Initial review completed: September 28, 1999;
Revision Accepted: October 25, 1999
Angioedema, characterized by non-pitting, erythematous swelling of soft tissues, can be hereditary or acquired. Hereditary angioedema (HAE) is an autosomal dominant disease due to mutations at C1 inhibitor gene. The defective gene does not produce sufficient levels of C1 inhibitor in plasma which leads to auto-activation of C1 and consumption of C2 and C4. It is further classified into Type I (lower production of C1 inhibitor proteins) and Type II (functional defect of C1 inhibitor with normal plasma levels)(1,2). Acquired angioedema may be a manifestation of urticaria; it has recently been described with drugs like angiotensin converting enzyme (ACE) inhibitors.

79. DI&DMH Research : Hereditary Angioedema
Genotypephenotype correlation in patients with hereditary angioedema hereditary angioedema (HAE) is a autosomal dominant disorder that results from an
http://www.molecular-haemostasis.de/research/hereditary.html
Institute of Transfusion Medicine and Immunohaematology
Department of Immunohaematology and
Department of Molecular Haemostasis
Head: Johannes Oldenburg (MD, PhD) Immunohaematology Molecular Haemostasis Education / Training ... Links Research : Hereditary Angioedema
Genotype-phenotype correlation in patients with Hereditary Angioedema
home contact print up

80. BioSpace News: Angioedema
(DYAX) Release DX88 Trials In hereditary angioedema To Be Featured At 4th (DYAX) Provides Update On DX-88 Development For hereditary angioedema;
http://www.biospace.com/news_rxtarget.cfm?RxTargetID=62620

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

Page 4     61-80 of 104    Back | 1  | 2  | 3  | 4  | 5  | 6  | Next 20

free hit counter